Summary:

- This article reports on a new study that has discovered a potential treatment for Alzheimer's disease. The study found that a compound called CMS121 was able to improve memory and cognitive function in mice with Alzheimer's-like symptoms.

- CMS121 works by targeting a specific protein called HDAC2, which is known to be involved in the development of Alzheimer's disease. By inhibiting HDAC2, the compound was able to restore normal brain function and reduce the buildup of harmful proteins associated with the disease.

- The researchers are hopeful that this discovery could lead to the development of a new drug for treating Alzheimer's disease in humans. However, further research is still needed to fully understand the mechanisms behind CMS121's effects and to test its safety and efficacy in clinical trials.